The proto-oncogene Cot kinase participates in CD3/CD28 induction of NF- κB acting through the NF-κB-inducing kinase and IκB kinases

Immunity

Volumn 10, Issue 2, 1999, Pages 271-280

  Xin, Lin ^a   Cunningham Jr , Emmett T ^a   Yajun, Mu ^a   Geleziunas, Romas ^a   Greene, Warner C ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD28 ANTIGEN; CD3 ANTIGEN; CYTOKINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN SERINE THREONINE KINASE; TRANSCRIPTION FACTOR; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; PRIORITY JOURNAL; PROTEIN ASSEMBLY; PROTEIN EXPRESSION; PROTEIN INDUCTION; PROTO ONCOGENE; SIGNAL TRANSDUCTION; T LYMPHOCYTE ACTIVATION;

EID: 0033082990     PISSN: 10747613     EISSN: None     Source Type: Journal    
DOI: 10.1016/s1074-7613(00)80027-8     Document Type: Article

References (57)

1. Baeuerle, P.A., and Baltimore, D. (1996). NF-κB: Ten years after. Cell 87, 13-20.
2. Baldwin, A.J. (1996). The NF-κB and IκB proteins: New discoveries and insights. Annu. Rev. Immunol. 14, 649-683.
3. Ballester, A., Tobena, R., Lisbona, C., Calvo, V., and Alemany, S. (1997). Cot kinase regulation of IL-2 production in Jurkat T cells. J. Immunol. 159, 1613-1618.
4. Beg, A.A., and Baltimore, D. (1996). An essential role for NF-κB in preventing TNFα-induced cell death. Science 274, 782-784.
5. Beg, A.A., Sha, W.C., Bronson, R.T., Ghosh, S., and Baltimore, D. (1995). Embryonic lethality and liver degeneration in mice lacking the RelA component of NF-κB. Nature 376, 167-170.
6. Boothby, M.R., Mora, A.L., Scherer, D.C., Brockman, J.A., and Ballard, D.W. (1997). Perturbation of the T lymphocyte lineage in transgenic mice expressing a constitutive repressor of nuclear factor NF-κB. J. Exp. Med. 185, 1897-1907.
7. Brockman, J.A., Scherer, D.C., McKinsey, T.A., Hall, S.M., Qi, X., Lee, W.Y., and Ballard, D.W. (1995). Coupling of a signal response domain in IκBα to multiple pathways for NF-κB activation. Mol. Cell. Biol. 15, 2809-2818.
8. Brown, K., Gerstberger, S., Carlson, L., Franzoso, G., and Siebenlist, U. (1995). Control of IκBα proteolysis by site-specific, signal-induced phosphorylation. Science 267, 1485-1488.
9. Ceci, J.D., Patriotis, C.P., Tsatsanis, C., Makris, A.M., Kovatch, R., Swing, D.A., Jenkins, N.A., Tsichlis, P.N., and Copeland, N.G. (1997). Tpl-2 is an oncogenic kinase that is activated by carboxy-terminal truncation. Genes Dev. 11, 688-700.
10. Chambers, C.A., and Allison, J.P. (1997). Co-stimulation in T cell responses. Curr. Opin. Immunol. 9, 396-404.
11. Chen, Z., Hagler, J., Palombella, V.J., Melandri, F., Scherer, D., Ballard, D., and Maniatis, T. (1995). Signal-induced site-specific phosphorylation targets IκBα to the ubiquitin-proteasome pathway. Genes Dev. 9, 1586-1597.
12. Crabtree, G.R., and Clipstone, N.A. (1994). Signal transmission between the plasma membrane and nucleus of T lymphocytes. Annu. Rev. Biochem. 63, 1045-1083.
13. DiDonato, J.A., Hayakawa, M., Rothwarf, D.M., Zandi, E., and Karin, M. (1997). A cytokine-responsive IκB kinase that activates the transcription factor NF-κB. Nature 388, 548-554.
14. Doi, T.S., Takahashi, T., Taguchi, O., Azuma, T., and Obata, Y. (1997). NF-κB RelA-deficient lymphocytes: Normal development of T cells and B cells, impaired production of IgA and IgG1 and reduced proliferative responses. J. Exp. Med. 185, 953-961.
15. Fraser, J.D., Irving, B.A., Crabtree, G.R., and Weiss, A. (1991). Regulation of interleukin-2 gene enhancer activity by the T cell accessory molecule CD28. Science 251, 313-316.
16. Geleziunas, R., Ferrell, S., Lin, X., Mu, Y., Cunningham, E.J., Grant, M., Connelly, M.A., Hambor, J.E., Marcu, K.B., and Greene, W.C. (1998). Human T-cell leukemia virus type 1 tax induction of NF-κB involves activation of the IκB kinase α (IKKα) and IκB kinase β (IKKκ) cellular kinases. Mol. Cell. Biol. 18, 5157-5165.
17. Ghosh, P., Tan, T.H., Rice, N.R., Sica, A., and Young, H.A. (1993). The interleukin 2 CD28-responsive complex contains at least three members of the NF-κB family: c-Rel, p50, and p65. Proc. Natl. Acad. Sci. USA 90, 1696-1700.
18. Harhaj, E.W., and Sun, S.C. (1998). IκB kinases serve as a target of CD28 signaling. J. Biol. Chem. 273 , 25185-25190.
19. Hoyos, B., Ballard, D.W., Bohnlein, E., Siekevitz, M., and Greene, W.C. (1989). Kappa B-specific DNA binding proteins: Role in the regulation of human interleukin-2 gene expression. Science 244, 457-460.
20. Jain, J., Loh, C., and Rao, A. (1995). Transcriptional regulation of the IL-2 gene. Curr. Opin. Immunol. 7, 333-342.
21. Karin, M., and Delhase, M. (1998). JNK or IKK, AP-1 or NF-κB, which are the targets for MEK kinase 1 action? Proc. Natl. Acad. Sci. USA 95, 9067-9069.
22. Kontgen, F., Grumont, R.J., Strasser, A., Metcalf, D., Li, R., Tarlinton, D., and Gerondakis, S. (1995). Mice lacking the c-rel proto-oncogene exhibit defects in lymphocyte proliferation, humoral immunity, and interleukin-2 expression. Genes Dev. 9, 1965-1977.
23. Lai, J.H., Horvath, G., Subleski, J., Bruder, J., Ghosh, P., and Tan, T.H. (1995). Rela is a potent transcriptional activator of the CD28 response element within the interleukin 2 promoter. Mol. Cell. Biol. 15, 4260-4271.
24. Lee, F.S., Peters, R.T., Dang, L.C., and Maniatis, T. (1998). MEKK1 activates both IκB kinase α and IκB kinase β. Proc. Natl. Acad. Sci. USA 95, 9319-9324.
25. Lin, X., Mu, Y., Cunningham, E.T., Marcu, K.B., Geleziunas, R.G., and Greene, W.C. (1998). Molecular determinants of NF-κB-inducing kinase action. Mol. Cell. Biol. 18, 5899-5907.
26. Ling, L., Cao, Z., and Goeddel, D.V. (1998). NF-κB-inducing kinase activates IKKα by phosphorylation of Ser-176. Proc. Natl. Acad. Sci. USA 95, 3792-3797.
27. Linsley, P.S., and Ledbetter, J.A. (1993). The role of the CD28 receptor during T cell responses to antigen. Annu. Rev. Immunol. 11, 191-212.
28. Liu, Z.G., Hsu, H., Goeddel, D.V., and Karin, M. (1996). Dissection of TNF receptor 1 effector functions: JNK activation is not linked to apoptosis while NF-κB activation prevents cell death. Cell 87, 565-576.
29. Maggirwar, S.B., Harhaj, E.W., and Sun, S.C. (1997). Regulation of the interleukin-2 CD28-responsive element by NF-ATp and various NF-κB/Rel transcription factors. Mol. Cell. Biol. 17, 2605-2614.
30. Makris, A., Patriotis, C., Bear, S.E., and Tsichlis, P.N. (1993). Genomic organization and expression of Tpl-2 in normal cells and moloney murine leukemia virus-induced rat T-cell lymphomas: Activation by provirus insertion. J. Virol. 67, 4283-4289.
31. Malinin, N.L., Boldin, M.P., Kovalenko, A.V., and Wallach, D. (1997). MAP3k-related kinase involved in NF-κB induction by TNF, CD95 and IL-1. Nature 385, 540-544.
32. McGuire, K.L., and Lacobelli, M. (1997). Involvement of Rel, Fos, and Jun proteins in binding activity to the IL-2 promoter CD28 response element/AP-1 sequence in human T cells. J. Immunol. 159, 1319- 1327.
33. Mercurio, F., Zhu, H., Murray, B.W., Shevchenko, A., Bennett, B.L., Li, J., Young, D.B., Barbosa, M., Mann, M., Manning, A., et al. (1997). IKK-1 and IKK-2: Cytokine-activated IκB kinases essential for NF- κB activation. Science 278, 860-866.
34. Miyoshi, J., Higashi, T., Mukai, H., Ohuchi, T., and Kakunaga, T. (1991). Structure and transforming potential of the human cot oncogene encoding a putative protein kinase. Mol. Cell. Biol. 11, 4088- 4096.
35. Patriotis, C., Makris, A., Bear, S.E., and Tsichlis, P.N. (1993). Tumor progression locus 2 (Tpl-2) encodes a protein kinase involved in the progression of rodent T-cell lymphomas and in T-cell activation. Proc. Natl. Acad. Sci. USA 90, 2251-2255.
36. Patriotis, C., Makris, A., Chernoff, J., and Tsichlis, P.N. (1994). Tpl-2 acts in concert with Ras and Raf-1 to activate mitogen-activated protein kinase. Proc. Natl. Acad. Sci. USA 91, 9755-9759.
37. Regnier, C.H., Song, H.Y., Gao, X., Goeddel, D.V., Cao, Z., and Rothe, M. (1997). Identification and characterization of an IκB kinase. Cell 90, 373-383.
38. Reuther, J.Y., Reuther, G.W., Cortez, D., Pendergast, A.M., and BaldWin, A.J. (1998). A requirement for NF-κB activation in Bcr-Abl-mediated transformation. Genes Dev. 12, 968-981.
39. Rooney, J.W., Sun, Y.L., Glimcher, L.H., and Hoey, T. (1995). Novel NFAT sites that mediate activation of the interleukin-2 promoter in response to T-cell receptor stimulation. Mol. Cell. Biol. 15, 6299- 6310.
40. Rudd, C.E. (1996). Upstream-downstream: CD28 cosignaling pathways and T cell function. Immunity 4, 527-534.
41. Salmeron, A., Ahmad, T.B., Carlile, G.W., Pappin, D., Narsimhan, R.P., and Ley, S.C. (1996). Activation of MEK-1 and SEK-1 by Tpl-2 proto-oncoprotein, a novel MAP kinase kinase kinase. EMBO J. 15, 817-826.
42. Scherer, D.C., Brockman, J.A., Chen, Z., Maniatis, T., and Ballard, D.W. (1995). Signal-induced degradation of IκBα requires site-specific ubiquitination. Proc. Natl. Acad. Sci. USA 92, 11259-11263.
43. Schwartz, R.H. (1992). Costimulation of T lymphocytes: The role of CD28, CTLA-4, and B7/BB1 in interleukin-2 production and immunotherapy. Cell 71, 1065-1068.
44. Shapiro, V.S., Truitt, K.E., Imboden, J.B., and Weiss, A. (1997). CD28 mediates transcriptional upregulation of the interleukin-2 (IL-2) promoter through a composite element containing the CD28RE and NF-IL-2B AP-1 sites. Mol. Cell. Biol. 17, 4051-4058.
45. Su, B., Jacinto, E., Hibi, M., Kallunki, T., Karin, M., and Ben, N.Y. (1994). JNK is involved in signal integration during costimulation of T lymphocytes. Cell 77, 727-736.
46. Sun, S., Elwood, J., and Greene, W.C. (1996). Both amino- and carboxyl-terminal sequences within IκBα regulate its inducible degradation. Mol. Cell. Biol. 16, 1058-1065.
47. Thanos, D., and Maniatis, T. (1995). NF-κB: A lesson in family values. Cell 80, 529-532.
48. Traenckner, E.B., Pahl, H.L., Henkel, T., Schmidt, K.N., Wilk, S., and Baeuerle, P.A. (1995). Phosphorylation of human IκBα on serines 32 and 36 controls IκB-α proteolysis and NF-κB activation in response to diverse stimuli. EMBO J. 14, 2876-2883.
49. Tsatsanis, C., Patriotis, C., Bear, S.E., and Tsichlis, P.N. (1998). The Tpl-2 protooncoprotein activates the nuclear factor of activated T cells and induces interleukin 2 expression in T cell lines. Proc. Natl. Acad. Sci. USA 95, 3827-3832.
50. Van, A.D., Martin, S.J., Kafri, T., Green, D.R., and Verma, I.M. (1996). Suppression of TNFα-induced apoptosis by NF-κB. Science 274, 787-789.
51. Verma, I.M., Stevenson, J.K., Schwarz, E.M., Van, A.D., and Miyamoto, S. (1995). Rel/NF-κB/IκB family: Intimate tales of association and dissociation. Genes Dev. 9, 2723-2735.
52. Wang, C.Y., Mayo, M.W., and Baldwin, A.J. (1996). TNF-and cancer therapy-induced apoptosis: Potentiation by inhibition of NF-κB. Science 274, 784-787.
53. Weiss, A., and Littman, D.R. (1994). Signal transduction by lymphocyte antigen receptors. Cell 76, 263-274.
54. Whiteside, S.T., Ernst, M.K., Lebail, O., Laurent, W.C., Rice, N., and Israel, A. (1995). N-and C-terminal sequences control degradation of MAD3/IκBα in response to inducers of NF-κB activity. Mol. Cell. Biol. 15, 5339-5345.
55. Woronicz, J.D., Gao, X., Cao, Z., Rothe, M., and Goeddel, D.V. (1997). IκB kinase-β: NF-κB activation and complex formation with kB kinase-α and NIK. Science 278, 866-869.
56. Yamaoka, S., Inoue, H., Sakurai, M., Sugiyama, T., Hazama, M., Yamada, T., and Hatanaka, M. (1996). Constitutive activation of NF- KB is essential for transformation of rat fibroblasts by the human T-cell leukemia virus type I Tax protein. EMBO J. 15, 873-887.
57. Zandi, E., Rothwarf, D.M., Delhase, M., Hayakawa, M., and Karin, M. (1997). The IκB kinase complex (IKK) contains two kinase subunits, IKKα and IKKβ, necessary for IκB phosphorylation and NF- κB activation. Cell 91, 243-252.